XML 51 R42.htm IDEA: XBRL DOCUMENT
v3.22.2

Financial Instruments and Fair Value Measurements - Equity Investment in Armata (Details) - Armata $ / shares in Units, $ in Millions |  | 3 Months Ended | 6 Months Ended
--- | --- | --- | ---
Feb. 09, 2022 USD ($) $ / shares shares | Jun. 30, 2022 USD ($) Director $ / shares | Dec. 31, 2021 USD ($) shares | Jun. 30, 2021 USD ($) | Mar. 31, 2021 USD ($) $ / shares shares | Mar. 31, 2020 USD ($) $ / shares shares | Jun. 30, 2022 USD ($) Tranche Director $ / shares | Jun. 30, 2021 USD ($)
Equity investment |  |  |  |  |  |  |  |
Number of tranches | Tranche |  |  |  |  |  |  | 2 |
Equity investment ownership percentage |  | 69.40% | 59.30% |  |  |  | 69.40% |
Percentage of maximum voting rights | 49.50% |  |  |  |  |  | 49.50% |
Number of Investee's Board members currently representing the Company | Director |  | 3 |  |  |  |  | 3 |
Number of the Investee's Board members | Director |  | 8 |  |  |  |  | 8 |
Unrealized gain from fair value changes in equity investments |  |  |  |  |  |  |  | $ 36.9
Unrealized loss from fair value changes in equity investments |  | $ 42.8 |  | $ 24.3 |  |  | $ 47.0 |
Two Directors |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Armata outstanding shares percentage | 12.50% |  |  |  |  |  |  |
Common stock and warrants |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Amount of securities purchase agreement |  |  |  |  |  | $ 25.0 |  |
Equity and long-term investments at fair value |  | $ 144.7 | $ 146.7 |  |  |  | $ 144.7 |
Warrants purchased in 2020 |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  | $ 2.87 |  |
Term of warrants |  | 5 years |  |  |  |  | 5 years |
Warrants purchased in 2021 |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  | $ 3.25 |  |  |
Term of warrants |  | 5 years |  |  |  |  | 5 years |
Warrants purchased in 2022 Member |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  | $ 5.00 |  |  |  |  | $ 5.00 |
Term of warrants |  | 5 years |  |  |  |  | 5 years |
Warrants |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Number of warrants purchased under the securities purchase agreement | shares |  |  |  |  |  | 8,710,800 |  |
Equity and long-term investments at fair value |  | $ 47.1 | $ 58.6 |  |  |  | $ 47.1 |
Common stock |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Number of shares to be purchased under the securities purchase agreement | shares |  |  |  |  |  | 8,710,800 |  |
Number of shares to be purchased under the securities purchase agreement | shares |  |  | 1,212,122 |  |  |  |  |
Amount of securities purchase agreement |  |  | $ 4.0 |  |  |  |  |
Equity and long-term investments at fair value |  | $ 97.6 | $ 88.1 |  |  |  | $ 97.6 |
Minimum [Member] | One Director |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Armata outstanding shares percentage | 8.00% |  |  |  |  |  |  |
Maximum [Member] | One Director |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Armata outstanding shares percentage | 12.50% |  |  |  |  |  |  |
Innoviva Strategic Opportunities, LLC | Common stock and warrants |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Amount of securities purchase agreement | $ 45.0 |  |  |  | $ 20.0 |  |  |
Innoviva Strategic Opportunities, LLC | Warrants |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Number of warrants to be purchased under the securities purchase agreement | shares | 4,500,000 |  |  |  | 6,153,847 |  |  |
Exercise price of warrants | $ / shares | $ 5.00 |  |  |  |  |  |  |
Innoviva Strategic Opportunities, LLC | Common stock |  |  |  |  |  |  |  |
Equity investment |  |  |  |  |  |  |  |
Number of shares to be purchased under the securities purchase agreement | shares | 9,000,000 |  |  |  | 6,153,847 |  |  |

X
- Definition The total number of Board members of the Investee. + References No definition available. + Details
Name: | inva_NumberOfBoardMembersOfInvestee
Namespace Prefix: | inva_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of the Company's Board members currently serving on the Investee's Board. + References No definition available. + Details
Name: | inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee
Namespace Prefix: | inva_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of warrants issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction
Namespace Prefix: | inva_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount the Company agreed to pay for common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement. + References No definition available. + Details
Name: | inva_SecuritiesPurchaseAgreementAmount
Namespace Prefix: | inva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of tranches in which the Company agreed to purchase common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement. + References No definition available. + Details
Name: | inva_SecuritiesPurchaseAgreementNumberOfTranches
Namespace Prefix: | inva_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The total number of shares to be purchased under the terms of a securities purchase agreement. + References No definition available. + Details
Name: | inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement
Namespace Prefix: | inva_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The total number of warrants to be purchased under the terms of a securities purchase agreement. + References No definition available. + Details
Name: | inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement
Namespace Prefix: | inva_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the percentage of maximum voting rights under voting agreement. + References No definition available. + Details
Name: | inva_VotingAgreementMaximumVotingRightsPercent
Namespace Prefix: | inva_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(2)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 45 -Paragraph 1A -URI https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740 + Details
Name: | us-gaap_EquitySecuritiesFvNi
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 321 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714 + Details
Name: | us-gaap_EquitySecuritiesFvNiUnrealizedGain
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 321 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714 + Details
Name: | us-gaap_EquitySecuritiesFvNiUnrealizedLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685 + Details
Name: | us-gaap_VariableInterestEntityOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=inva_TwoDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=inva_CommonStockAndWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=inva_OneDirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |